title: Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin.
authors.forename: Hebert Roberto
authors.initials: HR
authors.lastname: Clivati Brandt
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: de Lorenzo Messina
authors.forename: Walter
authors.initials: W
authors.lastname: Belda Júnior
authors.forename: Jose Eduardo
authors.initials: JE
authors.lastname: Costa Martins
authors.forename: Paulo Ricardo
authors.initials: PR
authors.lastname: Criado
mesh_terms: D017153:Antibodies, Anticardiolipin / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use; D005165:Factor V; D005260:Female; D006579:Heterozygote; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D011516:Prothrombin / Q000235:genetics*; D019851:Thrombophilia / Q000097:blood / Q000235:genetics*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V; D011516:Prothrombin; D042965:Methylenetetrahydrofolate Reductase (NADPH2)